Key facts
- AmplifyMD’s last known valuation is $181.0M (Sep 2025).
- It has raised $43.6M; the latest was Later Stage VC ($20.0M) in Sep 2025.
- Notable investors include F-Prime Capital, Greylock, Forerunner Ventures, Tau Ventures, Koa Labs — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for AmplifyMD
- ·The full record, as it builds
Funding rounds
No funding rounds for AmplifyMD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AmplifyMD
Developer of a virtual care technology designed for hospitals and health systems to build, manage, and scale quality remote clinical services. The company's platform integrates with electronic health records to deliver telehealth services at scale, offering features such as clinician collaboration, real-time patient data access, and secure communication tools, enabling healthcare providers to expand specialist access, improve care coordination, and enhance patient outcomes across diverse clinical environments.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2019
- Employees
- 50
- Website
- amplifymd.com/
- Ownership
- Privately Held (backing)
AmplifyMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AmplifyMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AmplifyMD in its N-PORT filings yet. We sweep new filings monthly.